// company-profile

Elicio Therapeutics, Inc.

ELTX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings48Insiders13
// api This Elicio Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for ELTX in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Elicio Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$32.5M
QoQ change
+71.0%
Reporting period
2026-03-31
#1
Knoll Capital Management, LLC
CIK 1325083
$6.7M
631K shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$5.5M
519K shares
#3
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CIK 1446194
$2.8M
258K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Feb 2, 2026Connelly RobertELTX
Award
73,600$0.00$0K
Feb 2, 2026Shah PreetamELTX
Award
47,900$0.00$0K
Feb 2, 2026Shah PreetamELTX
Award
24,000$0.00$0K
Feb 2, 2026Haqq ChristopherELTX
Award
50,900$0.00$0K
Feb 2, 2026Haqq ChristopherELTX
Award
25,400$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.